Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AMLX
TMDX
Add up to 3 more stocks
AMLX
Amylyx Pharmaceuticals, Inc.
+0.67%
$27.97+0.19Delayed quote: Oct 6, 2026, 11:31 AM EDT
Market Cap
$3.11B
52W Range
$10.83 - $41.14
TMDX
TransMedics Group, Inc.
-1.68%
$81.59-1.39Delayed quote: Oct 6, 2026, 11:31 AM EDT
Market Cap
$2.82B
52W Range
$60.10 - $156.00
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 21.14 |
| Forward P/E | N/A | 55.62 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 13.00 | 5.44 |
| P/S Ratio | N/A | 4.22 |
| P/FCF Ratio | N/A | 35.68 |
| EV/EBITDA | N/A | 27.24 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 58.7% |
| Operating Margin | 0.0% | 12.2% |
| Net Margin | 0.0% | 22.7% |
| ROE | -63.6% | 29.3% |
| ROA | -57.5% | 10.4% |
| ROIC | -66.6% | 5.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 12.12 | 6.62 |
| Quick Ratio | 12.12 | 6.07 |
| Debt/Equity | 0.02 | 1.67 |
| Interest Coverage | N/A | 7.88 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.